Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
Cart
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Home
Journals
Radiology and Oncology
Volume 53 (2019): Issue 2 (June 2019)
Open Access
The use of high-frequency short bipolar pulses in cisplatin electrochemotherapy in vitro
Maria Scuderi
Maria Scuderi
,
Matej Rebersek
Matej Rebersek
,
Damijan Miklavcic
Damijan Miklavcic
and
Janja Dermol-Cerne
Janja Dermol-Cerne
| Jun 01, 2019
Radiology and Oncology
Volume 53 (2019): Issue 2 (June 2019)
About this article
Previous Article
Next Article
Abstract
Article
Figures & Tables
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Article Category:
Research Article
Published Online:
Jun 01, 2019
Page range:
194 - 205
Received:
Feb 04, 2019
Accepted:
Apr 23, 2019
DOI:
https://doi.org/10.2478/raon-2019-0025
© 2019 Maria Scuderi, Matej Rebersek, Damijan Miklavcic, Janja Dermol-Cerne, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Figure 1
Scheme of the applied pulses. (A) 100 μs long monopolar pulses of amplitude ΔU (80 V – 240 V in a step of 40 V) were applied with a repetition frequency of 1 Hz. (B) Short bipolar pulses (HF-EP). Above: 8 bursts were applied with a repetition frequency of 1 Hz. Down left: One burst was 200 μs long and consisted of 50 bipolar pulses. Below right: One bipolar pulse of amplitude ΔU (100 V – 1000 V in a step of 100 V) consisted of 1 μs long positive pulse, 1 μs long negative pulse (both of voltage ΔU) with a 1 μs long delay between pulses.
Figure 2
Cell membrane permeability and cell survival as a function of electric field for (A) 8 x 100 μs long monopolar pulses, delivered at repetition frequency 1 Hz; (B) 8 bursts of short bipolar pulses (HF-EP) of 1-1-1-1 μs, delivered at repetition frequency 1 Hz. Each data point was repeated 3–4 times (mean ± standard deviation). In the control sample, no pulses were applied. Note different scales on the x-axes. On (A), the threshold of electroporation was at 0.8 kV/cm (P = 0.029, t-test) and survival did not decrease in comparison with control (one-sample t-test). On (B) the threshold of electroporation was at 2 kV/cm (P = 0.022, t-test), while the survival decreased at 4.5 kV/cm (P = 0.004, one-sample t-test). In Figure 2B, blue asterisks refer to permeability curve and red asterisks to the survival curve.
Figure 3
Cell membrane permeability as a function of different time of propidium iodide administration after electroporation for (A) 8 x 100 μs long monopolar pulses, delivered at a repetition frequency 1 Hz; (B) 8 bursts of short bipolar pulses (HF-EP) of 1-1-1-1 μs, delivered at repetition frequency 1 Hz. Each data point was repeated 4 times (mean ± standard deviation). We performed a 1-way ANOVA on ranks. For both types of pulses, there was a significant difference between 0 min vs 10 min and 20 min (P < 0.05), other pairwise comparisons were not significant.
Figure 4
Cytotoxicity of cisplatin without electroporation at different concentrations and time of incubation. Each data point was repeated 4 times (mean ± standard deviation) and is normalized to the control sample in which cisplatin was substituted by 0.9% NaCl. A 2-way ANOVA was performed. 10 min or 1 h of incubation was different from 24 h or 48 h (P < 0.001) while there was no difference between 10 min vs 1 h and 24 h vs 48 h. 330 μM cisplatin was more cytotoxic than other tested concentrations (P < 0.001). There was no significant difference between 1 μM and 10 μM cisplatin; all other comparisons were significantly different (P < 0.001).
Figure 5
Cytotoxicity of cisplatin in combination with electroporation (EP) at fixed value of cisplatin (CDDP) 100 μM as a function of electric field: (A) 8 x 100 μs long monopolar pulses (ECT) were delivered at repetition frequency 1 Hz; (B) 8 bursts of short bipolar pulses (HF-EP) of 1-1-1-1 μs were delivered at repetition frequency 1 Hz. Each data point was repeated 3–6 times (mean ± standard deviation). Results are normalized to the control sample without an electric field and with 100 μM cisplatin. We performed a (A) 2-way ANOVA or (B) 2-way ANOVA on ranks. (A) At 0.8 kV/cm (P = 0.036) and 1 kV/cm and 1.2 kV/cm (P < 0.001) EP samples were significantly different from CDDP+EP samples. (B) At electric fields equal to or higher than 2 kV/cm EP samples were significantly different from CDDP+EP samples (P < 0.001).
Figure 6
Cytotoxicity of cisplatin at different concentration of cisplatin (CDDP) and electroporation (EP) at a fixed value of electric field (A) 1.2 kV/cm, 8x100 μs long monopolar pulses, delivered at repetition frequency 1 Hz; (B) 3 kV/cm, 8 bursts of short bipolar pulses (HF-EP) of 1-1-1-1 μs, delivered at repetition frequency 1 Hz. Each data point was repeated 3-7 times (mean ± standard deviation). Each data was normalized to the control sample electroporated and with 0.9% NaCl instead of cisplatin. We performed a 2-way ANOVA. For both types of pulses, at 100 μM and 330 μM the CDDP samples were significantly different from the CDDP+EP samples (P < 0.001).
Preview